Prostaglandin E1 : First Stage Palliation in Neonates with Congenital Cardiac Defects

Indian Journal of Pediatrics

Volumn 65, Issue 2, 1998, Pages 211-216

  Bose Reddy, S Chandra ^a   Saxena, A ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apnoea; Ductus arteriosus; E type prostaglandins; Hyperthermia

Indexed keywords

PROSTAGLANDIN E1;

AORTA COARCTATION; AORTA STENOSIS; APNEA; CLINICAL ARTICLE; CONFERENCE PAPER; CONGENITAL HEART DISEASE; DRUG COST; DUCTUS ARTERIOSUS; GREAT VESSELS TRANSPOSITION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERTHERMIA; HYPOTENSION; INDIA; INFANT; INFUSION; LUNG ATRESIA; LUNG BLOOD FLOW; NEWBORN; PALLIATIVE THERAPY; SEIZURE;

EID: 0031841557     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02752297     Document Type: Article

References (15)

1. Coceani F, Olley PM. The response of the ductus arteriosus to the prostaglandins, Can J Physiol Pharmacol 1973; 51 : 220-225
2. Starling MB, Elliott RB. The effects of prostaglandins, prostaglandin inhibitors, and oxygen on closure of the ductus arteriosus, pulmonary arteries, and umbilical vessels in vitro. Prostaglandins 1974; 8 : 187-203.
3. Sharpe GL, Larsson KS. Studies on closure of the ductus arteriosus X. In vivo effect of prostaglandin. Prostaglandin 1975; 9 : 703-719.
4. Elliot RB, Starling MB, Neutze JM. Medical manipulation of the ductus arterisus. Lancet 1975; 1 : 140-142.
5. Olley PM, Coceani F, Bodach E. E-type prostaglandin : A new emergency therapy for certain cyanotic congenital heart malformations. Circulation 1975; 53 : 728-731.
6. Lewis AB, Takahashi M, Lurie PR. Administration of prostaglandin E1 in neonates with critical congenital cardiac defects. J. Pediatr 1978; 3 : 481-485.
7. Neutz JM, Starling MB, Elliot RB, Barret Boys BG. Palliation of cyanotic heart disease in infancy with E-type prostaglandins. Circulation, 1977; 55 : 238-241.
8. Radford DJ, Bloom KR, Coceani F, Fariello R, Olley PM. Prostaglandin E1 for interrupted aortic aorta in the neonate Lancet 1976; 1 : 95 (letter).
9. Lang P, Freed MD, Rosenthal A, Castenada AR, Nadas AS. The use of prostaglandin E1 in an infant with interruption of aortic arch. J. Pediatr. 1977; 91 : 805-807.
10. Lang P, Feed MD, Bierman FZ, Norwood WI, Nadas AS. Use of prostaglandin E1 in infants with d-transposition of the great arteries and intact ventricular septum. Am J Cardiol 1979; 44 : 76-81.
11. Benson LN, Olley PM, Patel RG, Coceani F, Rowe RD. Role of prostaglandin E1 infusion in the management of transposition of great arteries. Am J Cardiol 1979; 44 : 691-696.
12. Freed MD, Heyman MA, Lewis AB, Roehl SL, Kensey RC. Prostaglandin E1 in infants with ductus arteriosus dependent congenital heart disease. Circulation 1981; 64 : 899-905.
13. Lewis AB, Freed MD, Heyman MA, Roehl SL, Kensey RC. Side effect of therapy with prostaglandin in infants with critical congenital heart defects. Circulation, 1981; 64 : 893-898.
14. Rudolph AM, Heymann MA, Spitznas U. Hemodynamic considerations in the development of narrowing of the aorta. Am J Cardiol 1972; 30 : 514-525.
15. Talner NS Berman MA, Postnatal development of obstruction in coarctation of the aorta : role of the ductus arteriosus. Pediatrics 1975; 56 : 562-569.